BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15227685)

  • 1. Molecular stool screening for colorectal cancer.
    Mak T; Lalloo F; Evans DG; Hill J
    Br J Surg; 2004 Jul; 91(7):790-800. PubMed ID: 15227685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal screening of colorectal cancer.
    Loganayagam A
    Int J Clin Pract; 2008 Mar; 62(3):454-9. PubMed ID: 17887994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution to stool DNA testing for colorectal cancer.
    Tagore KS; Levin TR; Lawson MJ
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1225-33. PubMed ID: 15191503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stool-based DNA tests for colorectal cancer: clinical potential and early results.
    Ahlquist DA
    Rev Gastroenterol Disord; 2002; 2 Suppl 1():S20-6. PubMed ID: 12439395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon cancer screening strategies.
    Agrawal J; Syngal S
    Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The colorectal adenoma-carcinoma sequence.
    Leslie A; Carey FA; Pratt NR; Steele RJ
    Br J Surg; 2002 Jul; 89(7):845-60. PubMed ID: 12081733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic acids from intact epithelial cells as a target for stool-based molecular diagnosis of colorectal cancer.
    Spethmann S; Fischer C; Wagener C; Streichert T; Tschentscher P
    Int J Mol Med; 2004 Mar; 13(3):451-4. PubMed ID: 14767578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problems and prospects of non-invasive screening for colorectal cancer].
    Maev IV; Govorun VM; Kucheriavyĭ IuA; Golubev NN; Generozov EV; Maslov VV; LiubeznovA IIu; Kostin PA
    Klin Med (Mosk); 2009; 87(7):10-6. PubMed ID: 19705783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.
    Berger BM; Ahlquist DA
    Pathology; 2012 Feb; 44(2):80-8. PubMed ID: 22198259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive testing for colorectal cancer: a review.
    Ouyang DL; Chen JJ; Getzenberg RH; Schoen RE
    Am J Gastroenterol; 2005 Jun; 100(6):1393-403. PubMed ID: 15929776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stool test for colorectal cancer screening: what is going on?
    Bonanno E; Rulli F; Galatà G; Pucci S; Sesti F; Farinon AM; Spagnoli LG
    Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stool test for colorectal cancer screening--it's time to move!
    Loitsch SM; Shastri Y; Stein J
    Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of stool DNA mutations before and after treatment of colorectal neoplasia.
    Syngal S; Stoffel E; Chung D; Willett C; Schoetz D; Schroy P; Jagadeesh D; Morel K; Ross M
    Cancer; 2006 Jan; 106(2):277-83. PubMed ID: 16342248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.
    Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
    Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
    Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection.
    Brand RE; Ross ME; Shuber AP
    Am J Gastroenterol; 2004 Jul; 99(7):1338-41. PubMed ID: 15233675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
    Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests.
    Berger BM; Schroy PC; Rosenberg JL; Lai-Goldman M; Eisenberg M; Brown T; Rochelle RB; Billings PR
    Clin Colorectal Cancer; 2006 Jan; 5(5):338-43. PubMed ID: 16512992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient perceptions of stool-based DNA testing for colorectal cancer screening.
    Schroy PC; Heeren TC
    Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.